Caveolin-1 and Sox-2 are predictive biomarkers of cetuximab response in head and neck cancer.
Jci Insight
Bouhaddou, Mehdi M; Lee, Rex H RH; Li, Hua H; Bhola, Neil E NE; O'Keefe, Rachel A RA; Naser, Mohammad M; Zhu, Tian Ran TR; Nwachuku, Kelechi K; Duvvuri, Umamaheswar U; Olshen, Adam B AB; Roy, Ritu R; Hechmer, Aaron A; Bolen, Jennifer J; Keysar, Stephen B SB; Jimeno, Antonio A; Mills, Gordon B GB; Vandenberg, Scott S; Swaney, Danielle L DL; Johnson, Daniel E DE; Krogan, Nevan J NJ; Grandis, Jennifer R JR